ASSESSMENT AND OCCURENCE OF ADVERSE EFFECTS AFTER CONSUMPTION OF SIDDHA DRUGS HOSPITAL BASED CROSS SECTIONAL STUDY

ASSESSMENT AND OCCURENCE OF ADVERSE EFFECTS AFTER CONSUMPTION OF SIDDHA DRUGS

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

CTRI

Registry ID

CTRI/2018/06/014412

Enrollment

100

Registered

2018-06-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients reporting with adverse effects after consumption of siddha drugs

Interventions

Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: patients reporting with adverse effect after taking siddha medicines in NIS OPD

Exclusion criteria

Exclusion criteria: allopathy or any other alternative medicine taken from outside

Design outcomes

Primary

Measure	Time frame
Document the adverse effects of siddha medicineTimepoint: Document the adverse effects of siddha medicine in national institute of siddha	—

Secondary

Measure	Time frame
provide information about the characteristics of adverse effectsTimepoint: 1 visit	—

Countries

India

Contacts

Public Contactdr madhavan

National institute of siddha tambaram sanatorium

nanjunoolnis@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026